Get informed when a big investor buys or sells
+ FollowOvervalued by 168.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $598.49 Million |
|---|---|
| Enterprise Value | $405.86 Million |
| Earnings per Share | $0.8 |
| Beta | 1.46 |
| Outstanding Shares | 31,499,470 |
| P/E Ratio | 50.37 |
|---|---|
| PEG | 5.43 |
| Price to Sales | 0.63 |
| Price to Book Ratio | 0.27 |
| Enterprise Value to Revenue | 0.42 |
| Enterprise Value to EBIT | 3.36 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 0.05 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothen...